Found: 156
Select item for more details and to access through your institution.
Pharmacy‐led pharmacovigilance: Ready for use or missed opportunity?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 12, p. 1562, doi. 10.1002/pds.4901
- By:
- Publication type:
- Article
The accuracy of date of death recording in the Clinical Practice Research Datalink GOLD database in England compared with the Office for National Statistics death registrations.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 5, p. 563, doi. 10.1002/pds.4747
- By:
- Publication type:
- Article
Reviewers of manuscripts submitted in 2016: With appreciation.
- Published in:
- 2017
- By:
- Publication type:
- Other
Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2017, v. 26, n. 1, p. 1, doi. 10.1002/pds.4125
- By:
- Publication type:
- Article
Reviewers of Manuscripts Submitted in 2015: With Appreciation.
- Published in:
- 2017
- By:
- Publication type:
- Other
Validity of diagnostic codes and laboratory measurements to identify patients with idiopathic acute liver injury in a hospital database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, p. 21, doi. 10.1002/pds.3824
- By:
- Publication type:
- Article
Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, p. 88, doi. 10.1002/pds.3862
- By:
- Publication type:
- Article
The effect of exposure misclassification in spontaneous ADR reports on the time to detection of product-specific risks for biologicals: a simulation study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 3, p. 297, doi. 10.1002/pds.3929
- By:
- Publication type:
- Article
Regulatory decision-making: are we getting it right?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 10, p. 1012, doi. 10.1002/pds.3695
- By:
- Publication type:
- Article
Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2012, v. 21, n. 5, p. 507, doi. 10.1002/pds.3234
- By:
- Publication type:
- Article
Measuring exacerbations in obstructive lung disease.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2010, v. 19, n. 4, p. 367, doi. 10.1002/pds.1892
- By:
- Publication type:
- Article
Cardiovascular and psychiatric risk profile and patterns of use in patients starting anti-obesity drugs.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2009, v. 18, n. 7, p. 631, doi. 10.1002/pds.1759
- By:
- Publication type:
- Article
Pharmacogenetics of drug-induced arrhythmias: a feasibility study using spontaneous adverse drug reactions reporting data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 2, p. 99, doi. 10.1002/pds.1194
- By:
- Publication type:
- Article
The trade-off between cardiovascular and gastrointestinal effects of rofecoxib.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2005, v. 14, n. 7, p. 437, doi. 10.1002/pds.1123
- By:
- Publication type:
- Article
Pharmacy data-a complete picture?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 12, p. 879, doi. 10.1002/pds.1018
- By:
- Publication type:
- Article
Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. E2, doi. 10.1002/ajh.26007
- By:
- Publication type:
- Article
Switching TNFα inhibitors: Patterns and determinants.
- Published in:
- Pharmacology Research & Perspectives, 2021, v. 9, n. 4, p. 1, doi. 10.1002/prp2.843
- By:
- Publication type:
- Article
Outcomes of a Postexposure Prophylaxis Program at the Korle-Bu Teaching Hospital in Ghana: A Retrospective Cohort Study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Relationship between Age and the Ability to Break Scored Tablets.
- Published in:
- Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00222
- By:
- Publication type:
- Article
Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, p. 19, doi. 10.1111/dom.13453
- By:
- Publication type:
- Article
Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 401, doi. 10.1111/dom.12833
- By:
- Publication type:
- Article
Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 421, doi. 10.1111/dom.12843
- By:
- Publication type:
- Article
Comment on "Deterministic Sensitivity Analysis Under Ignorance".
- Published in:
- 2021
- By:
- Publication type:
- Letter
The Application and Implications of Novel Deterministic Sensitivity Analysis Methods.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 1, p. 1, doi. 10.1007/s40273-020-00979-3
- By:
- Publication type:
- Article
Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia.
- Published in:
- Patient Preference & Adherence, 2016, v. 10, p. 2369, doi. 10.2147/PPA.S116860
- By:
- Publication type:
- Article
Safety-Related Regulatory Actions for Biologicals Approved in the United States and the European Union.
- Published in:
- JAMA: Journal of the American Medical Association, 2008, v. 300, n. 16, p. 1887, doi. 10.1001/jama.300.16.1887
- By:
- Publication type:
- Article
Gastric Acid-Suppressive Agents and Risk of Clostridium difficile-Associated Disease.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs.
- Published in:
- International Journal of Health Policy & Management, 2022, v. 11, n. 5, p. 642, doi. 10.34172/ijhpm.2020.198
- By:
- Publication type:
- Article
Medicine shortages: impact behind numbers.
- Published in:
- Journal of Pharmaceutical Policy & Practice, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s40545-023-00548-x
- By:
- Publication type:
- Article
Longitudinal study of Good Pharmacy Practice roles covered at the annual world pharmacy congresses 2003–2019.
- Published in:
- Journal of Pharmaceutical Policy & Practice, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s40545-022-00482-4
- By:
- Publication type:
- Article
Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement.
- Published in:
- International Journal of Technology Assessment in Health Care, 2023, v. 39, n. 1, p. 1, doi. 10.1017/S0266462323000144
- By:
- Publication type:
- Article
Addressing uncertainty in relative effectiveness assessments by HTA organizations.
- Published in:
- International Journal of Technology Assessment in Health Care, 2022, v. 38, n. 1, p. 1, doi. 10.1017/S026646232100177X
- By:
- Publication type:
- Article
Addressing uncertainty in relative effectiveness assessments by HTA organizations.
- Published in:
- International Journal of Technology Assessment in Health Care, 2021, v. 38, n. 1, p. 1, doi. 10.1017/S026646232100177X
- By:
- Publication type:
- Article
Comparing amikacin and kanamycininduced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.
- Published in:
- BMC Pharmacology & Toxicology, 2015, v. 16, p. 1, doi. 10.1186/s40360-015-0036-7
- By:
- Publication type:
- Article
Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia.
- Published in:
- Applied Health Economics & Health Policy, 2019, v. 17, n. 6, p. 883, doi. 10.1007/s40258-019-00496-1
- By:
- Publication type:
- Article
Impact of medicine shortages on patients - a framework and application in the Netherlands.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of medicine shortages on patients - a framework and application in the Netherlands.
- Published in:
- BMC Health Services Research, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12913-022-08765-x
- By:
- Publication type:
- Article
Reimbursement restriction and moderate decrease in benzodiazepine use in general practice.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Reimbursement Restriction and Moderate Decrease in Benzodiazepine Use in General Practice.
- Published in:
- Annals of Family Medicine, 2012, v. 10, n. 1, p. 42, doi. 10.1370/afm.1319
- By:
- Publication type:
- Article
What Drives Prescribing of Asthma Medication to Children? A Multilevel Population-Based Study.
- Published in:
- Annals of Family Medicine, 2009, v. 7, n. 1, p. 32, doi. 10.1370/afm.910
- By:
- Publication type:
- Article
Uptake of orphan drugs in the WHO essential medicines lists.
- Published in:
- Bulletin of the World Health Organization, 2024, v. 102, n. 1, p. 22, doi. 10.2471/BLT.23.289731
- By:
- Publication type:
- Article
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries.
- Published in:
- Bulletin of the World Health Organization, 2014, v. 92, n. 9, p. 630, doi. 10.2471/BLT.13.129114
- By:
- Publication type:
- Article
Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases.
- Published in:
- Bulletin of the World Health Organization, 2009, v. 87, n. 7, p. 520, doi. 10.2471/BLT.08.058925
- By:
- Publication type:
- Article
"Rare essentials": drugs for rare diseases as essential medicines.
- Published in:
- Bulletin of the World Health Organization, 2006, v. 84, n. 9, p. 745, doi. 10.2471/BLT.06.031518
- By:
- Publication type:
- Article
Increased use of antimicrobial agents and hospital admission for infections in patients with primary adrenal insufficiency: a cohort study.
- Published in:
- European Journal of Endocrinology, 2013, v. 168, n. 4, p. 609, doi. 10.1530/EJE-12-0879
- By:
- Publication type:
- Article
In reply to: Knowledge of developmental pharmacology and modeling approaches should be used to avoid useless trials in children.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Predictors of orphan drug approval in the European Union.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 5, p. 545, doi. 10.1007/s00228-007-0454-6
- By:
- Publication type:
- Article
Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 4, p. 405, doi. 10.1007/s00228-007-0407-0
- By:
- Publication type:
- Article